End-of-Life Care Preparedness Program for Senior Nursing Students

December 2, 2025 updated by: Hilal ALTUNDAL DURU

End-of-Life Care Preparedness Program for Senior Nursing Students: Effects on Attitudes and Self-Efficacy in a Randomized Controlled Trial

In this study, between 1 April- 31 May 2025, who met the inclusion and exclusion criteria, a total of 59 senior nursing students who are with 4th year nursing students starting the Nursing Department of Çankırı Karatekin University and Sakarya Applied Sciences University.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The End-of-Life Care Preparedness Program will be held in a online environment for the students in the intervention group. This training program has been developed based on the literature. The primary aim of the program was to enable participants to recognize their own thoughts and emotions about death, and to support their development in key areas of end-of-life care. Specifically, the content addressed providing care to dying individuals, caring for the deceased person, preparing the body after death, and offering psychosocial support to the bereaved family. The intervention consisted of four weekly sessions, each lasting approximately 90 minutes, delivered in an online group format via online. The training program will be applied to 29 senior nursing students in the intervention group. The sessions were structured to include psychoeducational content, interactive exercises, group discussions, and opportunities for reflection.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
59

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Center
      • Çankırı, Center, Turkey (Türkiye), 18100
        • Çankırı Karatekin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • final-year nursing students
  • consent to take part voluntarily
  • accessed to the required technology and competencies for attending online sessions

Exclusion Criteria:

  • failed to complete the data collection tools in full
  • missed intervention sessions
  • chosed to withdraw at any point during the intervention or follow-up phase

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention
The End-of-Life Care Preparedness Program will be held in a online environment for the students in the intervention group. This training program has been developed based on the literature. The primary aim of the program was to enable participants to recognize their own thoughts and emotions about death, and to support their development in key areas of end-of-life care. Specifically, the content addressed providing care to dying individuals, caring for the deceased person, preparing the body after death, and offering psychosocial support to the bereaved family. The intervention consisted of four weekly sessions, each lasting approximately 90 minutes, delivered in an online group format via online. The training program will be applied to 29 senior nursing students in the intervention group. The sessions were structured to include psychoeducational content, interactive exercises, group discussions, and opportunities for reflection.
Other: The End-of-Life Care Preparedness Program
The End-of-Life Care Preparedness Program will be held in a online environment for the students in the intervention group. This training program has been developed based on the literature. The primary aim of the program was to enable participants to recognize their own thoughts and emotions about death, and to support their development in key areas of end-of-life care. Specifically, the content addressed providing care to dying individuals, caring for the deceased person, preparing the body after death, and offering psychosocial support to the bereaved family. The intervention consisted of four weekly sessions, each lasting approximately 90 minutes, delivered in an online group format via online. The training program will be applied to 29 senior nursing students in the intervention group. The sessions were structured to include psychoeducational content, interactive exercises, group discussions, and opportunities for reflection.
No Intervention: Control
There will be no training or intervention.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Frommelt Attitudes Toward Care of the Dying Scale (FATCOD)
Time Frame: Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).
The FATCOD, originally developed by Frommelt (1991), was used to assess participants' attitudes toward caring for dying patients. The Turkish adaptation and validation of the scale was conducted by Çevik and Kav (2013). The scale contains 30 items rated on a 5-point Likert scale and includes both positively and negatively worded statements. Negative items are reverse-coded before computing the total score, which ranges from 30 to 150, with higher scores indicating more positive attitudes toward caring for dying patients. In the Turkish validation study, the Cronbach's alpha reliability coefficient was reported as 0.73.
Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).
End-of-Life and Postmortem Self-Efficacy Scale (ELPSES)
Time Frame: Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).
This instrument was evaluate nursing students' self-efficacy regarding end-of-life and postmortem care. The scale consists of 18 items and is formatted as a visual analog scale. For each item, participants indicate their perceived level of self-efficacy on a continuum from 0 (not confident at all) to 100 (extremely confident) using a slider mechanism. The overall self-efficacy score is calculated by averaging responses across items. In the original development study, the Cronbach's alpha for the scale was reported as 0.93.
Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hilal ALTUNDAL DURU

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Hilal ALTUNDAL DURU, PhD, Çankırı Karatekin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 31, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 20, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 20, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 2, 2025

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 9, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 2, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KaratekinU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings